TipRanks
Advertisement
Advertisement
Genfit Targets Non‑Invasive MASH Diagnostics Growth After U.S. Reimbursement Win for NASHnext
PremiumCompany AnnouncementsGenfit Targets Non‑Invasive MASH Diagnostics Growth After U.S. Reimbursement Win for NASHnext
1M ago
Genfit announces intention to voluntarily delist ADSs from Nasdaq
Premium
The Fly
Genfit announces intention to voluntarily delist ADSs from Nasdaq
12M ago
Genfit price target lowered to $7 from $9 at H.C. Wainwright
Premium
The Fly
Genfit price target lowered to $7 from $9 at H.C. Wainwright
1y ago
Genfit SA Reports Profit and Strategic Advances in 2024
PremiumCompany AnnouncementsGenfit SA Reports Profit and Strategic Advances in 2024
1y ago
Genfit announces final terms for dual proposal to 2025 Oceanes holders
Premium
The Fly
Genfit announces final terms for dual proposal to 2025 Oceanes holders
2y ago
Genfit SA’s Promising Clinical Milestones and Financial Stability Underpin Buy Rating
Premium
Ratings
Genfit SA’s Promising Clinical Milestones and Financial Stability Underpin Buy Rating
2y ago
Genfit price target raised to $13 from $11 at H.C. Wainwright
PremiumThe FlyGenfit price target raised to $13 from $11 at H.C. Wainwright
2y ago
Genfit SA (ADR) trading resumes
Premium
The Fly
Genfit SA (ADR) trading resumes
2y ago
Genfit SA (ADR) trading halted, news pending
Premium
The Fly
Genfit SA (ADR) trading halted, news pending
2y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―